These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 25640386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL, Xue YL, Song HJ, Luo QY.
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.
    Zhang L, Chen L, Xie Q, Zhang Y, Cheng L, Li H, Wang J.
    BMC Med Imaging; 2015 Mar 01; 15():7. PubMed ID: 25885599
    [Abstract] [Full Text] [Related]

  • 4. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
    Aryal A, Kumar VS, Shamim SA, Gamanagatti S, Khan SA.
    Clin Orthop Relat Res; 2021 Aug 01; 479(8):1768-1779. PubMed ID: 33635285
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
    Pietrzak AK, Czepczynski R, Wierzchoslawska E, Cholewinski W.
    Urol J; 2018 Sep 26; 15(5):242-247. PubMed ID: 29681049
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer.
    Al-Muqbel KM, Yaghan RJ.
    Medicine (Baltimore); 2016 May 26; 95(21):e3753. PubMed ID: 27227942
    [Abstract] [Full Text] [Related]

  • 8. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I.
    J Nucl Med; 2006 Feb 26; 47(2):287-97. PubMed ID: 16455635
    [Abstract] [Full Text] [Related]

  • 9. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
    Caglar M, Kupik O, Karabulut E, Høilund-Carlsen PF.
    Rev Esp Med Nucl Imagen Mol; 2016 Feb 26; 35(1):3-11. PubMed ID: 26514321
    [Abstract] [Full Text] [Related]

  • 10. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by 18F-FDG PET/CT. The role of 99mTc-MDP.
    Pietrzak A, Czepczynski R, Wierzchoslawska E, Cholewinski W.
    Hell J Nucl Med; 2017 Feb 26; 20(3):237-240. PubMed ID: 29177262
    [Abstract] [Full Text] [Related]

  • 11. The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer.
    Min JW, Um SW, Yim JJ, Yoo CG, Han SK, Shim YS, Kim YW.
    J Korean Med Sci; 2009 Apr 26; 24(2):275-80. PubMed ID: 19399270
    [Abstract] [Full Text] [Related]

  • 12. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.
    Krüger S, Buck AK, Mottaghy FM, Hasenkamp E, Pauls S, Schumann C, Wibmer T, Merk T, Hombach V, Reske SN.
    Eur J Nucl Med Mol Imaging; 2009 Nov 26; 36(11):1807-12. PubMed ID: 19504092
    [Abstract] [Full Text] [Related]

  • 13. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
    Chakraborty D, Bhattacharya A, Mete UK, Mittal BR.
    Clin Nucl Med; 2013 Aug 26; 38(8):616-21. PubMed ID: 23603596
    [Abstract] [Full Text] [Related]

  • 14. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A.
    J Nucl Med; 2015 Dec 26; 56(12):1862-8. PubMed ID: 26405167
    [Abstract] [Full Text] [Related]

  • 15. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
    Kim MR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2008 Feb 26; 44(2):148-52. PubMed ID: 17350879
    [Abstract] [Full Text] [Related]

  • 16. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Al-Bulushi NK, Abouzied ME.
    Nucl Med Commun; 2016 Jun 26; 37(6):583-8. PubMed ID: 26813992
    [Abstract] [Full Text] [Related]

  • 17. Is there any significance of lung cancer histology to compare the diagnostic accuracies of (18)F-FDG-PET/CT and (99m)Tc-MDP BS for the detection of bone metastases in advanced NSCLC?
    Inal A, Kaplan MA, Kucukoner M, Urakcı Z, Dostbil Z, Komek H, Onder H, Tasdemir B, Isıkdogan A.
    Contemp Oncol (Pozn); 2014 Jun 26; 18(2):106-10. PubMed ID: 24966793
    [Abstract] [Full Text] [Related]

  • 18. Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
    Gerety EL, Lawrence EM, Wason J, Yan H, Hilborne S, Buscombe J, Cheow HK, Shaw AS, Bird N, Fife K, Heard S, Lomas DJ, Matakidou A, Soloviev D, Eisen T, Gallagher FA.
    Ann Oncol; 2015 Oct 26; 26(10):2113-8. PubMed ID: 26202597
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY, Gill CM, Joseph Simeone F, Taneja AK, Huang AJ, Torriani M, Bredella MA.
    Acta Radiol; 2016 Jan 26; 57(1):58-65. PubMed ID: 25533313
    [Abstract] [Full Text] [Related]

  • 20. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
    Sahin E, Zincirkeser S, Akcan AB, Elboga U.
    J BUON; 2014 Jan 26; 19(1):291-6. PubMed ID: 24659678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.